By Compound (Carbon (13C), Nitrogen (15N), Deuterium, Oxygen (18O), Others), By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others), By Substance (Nucleic Acids, Amino Acids, Drugs/Metabolites) , fatty acids/lipids, NMR solvents, etc.), by indication (cardiovascular, neurology, inflammation, metabolic diseases, etc.), by method (chemicals, cell culture), by end-user (pharmaceutical and biotech companies, academic laboratories) and others), by region, competition, forecasts and opportunities, 2028.
NEW YORK, Dec. 29, 2022 (GLOBE NEWSWIRE) — Reportlinker.com Announces Release of Report “Stable Isotope Labeled Compounds Market – Global Industry Size, Shares, Trends, Opportunities and Forecasts, 2018-2028” – https://www.reportlinker.com/p06377496/?utm_source=GNW
Global stable isotope-labeled compounds are expected to grow at a significant rate during the forecast period of 2024-2028. Together, they are expected to drive market growth.
According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, killing nearly 10 million people in 2020, or 1 in 6. The most common cancers are lung, breast, and colon. rectal and prostate cancer.
Stable isotope-labeled compounds are used to check isotope pathways during chemical metabolism or to detect the presence of isotopes in cells. Therefore, they are commonly used in the biomedical research and R&D sector, which in turn drives market growth. .
In addition, increased investment in research and development programs by biotechnology and pharmaceutical companies and surge in demand for new effective therapeutics and diagnostics are expected to drive the market growth.
However, the inability to purchase stable isotope-labeled compounds due to high cost is expected to slow down the market growth. Also, the shortage of skilled professionals to conduct research activities is expected to hinder the market growth in the coming years.
The global stable isotope labeled compounds market is segmented into compound, application, substance, indication, method, end-user, company, and region. The end-user segment is further subdivided into pharmaceutical and biotech companies, academic institutions, and others.
Among them, the pharmaceutical and biotechnology companies segment is expected to be the fastest growing segment in the next few years. This is due to the increase in research and development costs and the increasing use of stable isotope-labeled compounds in research and development by pharmaceutical and biotechnology companies.
Based on region, the global stable isotope labeled compounds market is segmented into Asia Pacific, Europe, North America, South America, Middle East and Africa.As of 2022, North America will dominate the stable isotope labeled compounds market is expected to be the forecast period.
This is due to the presence of various stable isotope-based research companies and increasing support to the sector from the Isotope Production and Distribution Program Fund.
Major Players in the Global Stable Isotope Labeled Compounds Market include PerkinElmer Inc., Merck KGaA, 3M, Cambridge Isotope Laboratories, Inc., JSC Isotope, Creative Proteomics, Medical Isotopes, Inc., Omicron Biochemicals, Inc., Trace Includes Sciences International. , Nippon Sanso Holdings Corporation.
Purpose of the survey:
• Analyze and forecast the market size of the global stable isotope labeled compounds market.
• To categorize and forecast the global stable isotope labeled compounds market based on compound, application, substance, indication, method, end-user, region and company.
• Identify the drivers and challenges of the global stable isotope labeled compounds market.
• Examine competitive developments such as expansions, new product launches, mergers and acquisitions in the global stable isotope labeled compounds market.
• Conduct a price analysis of the global stable isotope labeled compound market.
• To identify and analyze profiles of key players operating in the global stable isotope labeled compounds market.
Analysts conducted both primary research and exhaustive secondary research for this study. First, analysts got a list of manufacturers around the world.
Analysts then conducted a primary research study on the identified companies. During the interview, respondents were also asked about their competitors.
This technique allows analysts to include manufacturers that could not be identified due to secondary research limitations. Analysts have examined the presence of manufacturers, distribution channels, and all major players across the globe.
Analysts have calculated the market size of the global stable isotope labeled compounds market using a bottom-up approach. Here, data for various end-user segments were recorded and projections made for the next few years. Analysts obtain these values from industry experts and company representatives and analyze and externally validate historical data for these product types and applications to obtain appropriate overall market size. did.
Analysts also examined various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports.
Main target audience:
• Market players, suppliers, distributors and other stakeholders of stable isotope labeled compounds.
• Biotech and pharmaceutical companies
• Government agencies such as regulators and policy makers;
• Organizations, forums and alliances related to stable isotope labeled compounds
• Market research and consulting firms
This research helps provide answers to some key questions that matter to industry stakeholders such as manufacturers, partners, and end-users. We also help you strategize your investments and take advantage of market opportunities.
Reporting scope:
In this report, the global Stable Isotope Labeled Compounds market is segmented into following categories along with the industry trends detailed below:
Stable Isotope Labeled Compounds Market, By Compound:
o Carbon (13C)
o Nitrogen (15N)
o Deuterium
Oxygen (18O)
o other
Stable Isotope Labeled Compounds Market by Application:
o Diagnosis
o Drug discovery
o Imaging
o sterilization
o other
• Stable Isotope Labeled Compounds Market, By Substance:
o Nucleic acid
o amino acid
o drug/metabolite
o Fatty acids/lipids
o NMR solvent
o other
• Stable Isotope Labeled Compounds Market by Indications:
o Cardiology
o Neurology
o Inflammation
o Metabolic disease
o other
• Stable Isotope Labeled Compounds Market by Method:
o chemical
o cell culture
Stable Isotope Labeled Compounds Market by End User:
o Pharmaceutical and biotech companies
o academic institutions
o other
Stable Isotope Labeled Compounds Market by Region:
o Asia Pacific
China
India
Japan
Korea
Australia
o Europe
France
Germany
England
Italy
Spain
o North America
America
Mexico
Canada
South America
Brazil
Argentina
Columbia
o Middle East and Africa
South Africa
Saudi Arabia
United Arab Emirates
competitive environment
Company Profiles: An in-depth analysis of the major players present in the global stable isotope labeled compounds market.
Customization available:
Using the market data given, we offer customization according to the specific needs of the company. The following customization options are available for reports:
About us
• Detailed analysis and profiling of additional market players (up to 5).
Read the full report: https://www.reportlinker.com/p06377496/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can instantly get all the market research you need in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
